Aclaris Therapeutics, Inc. IPO Info
Company Name: Aclaris Therapeutics, Inc.
Stock Symbol: ACRS
Exchange: NASDAQ
Status: Priced
IPO Date: 10/7/2015
IPO Price:
11.00 (
144.91%)
Underwriters
Jefferies, Citigroup, William Blair
Amount of Offering: N/A
Number of Shares Offered: 5 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Aclaris Therapeutics is a clinical-stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated topical drugs to address significant unmet needs in dermatology.
SEC Filings
News Headlines
